Published in Biotech Business Week, July 5th, 2010
"Protein pharmaceuticals have been becoming powerful and indispensable in combating human diseases due to the fact that they have high specificity and activity even at relatively low concentration. The present work deals with functionalization of nanodiamond particles for protein drug delivery applications. N,O-carboxymethyl chitosan (CMCS) is employed to modify the surface properties of pristine ND particles...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.